Condition: Prolonged Grief Disorder · Sponsor: University of Virginia
The primary purpose of this study is to explore the feasibility of conducting a clinical trial on the effects of psilocybin for individuals with prolonged grief disorder (PGD).
This description comes directly from the study's public registry record.
Fatma Wise, PhD · (434) 243-0568 · uvagrieftrial@uvahealth.org
Madison Focht · uvagrieftrial@uvahealth.org
Always discuss trial participation with your own doctor first.
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06724289